| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Oct 24 | INZY Inozyme Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 5.06 | 56,000 | 283.36 k | 56,000 |
| 31 May 24 | DNLI Denali Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 5,967 | 0.00 | 17,052 |
| 31 May 24 | DNLI Denali Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.56 | 17,901 | 332.24 k | 17,901 |
| 1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 53.76 | 4,768 | 256.33 k | 67,163 |
| 1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 957 | 0.00 | 71,638 |
| 1 Mar 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 19,400 | 0.00 | 70,681 |
| 1 Mar 24 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 53.69 | 34,200 | 1.84 mm | 34,200 |
| 5 Sep 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 37.96 | 6,000 | 227.76 k | 51,281 |
